Riboflavin transporter deficiency in young adults unmasked by dietary changes

Author:

Jaeger Bregje1,Langeveld Mirjam2,Brunkhorst Robert3,Distelmaier Felix4,Pop Ana5,Wolf Nicole I.6,Bosch Annet M.7ORCID

Affiliation:

1. Department of Child Neurology Emma Children's Hospital, Amsterdam University Medical Centers Amsterdam The Netherlands

2. Department of Endocrinology and Metabolism Amsterdam University Medical Centers Amsterdam The Netherlands

3. Department of Neurology Aachen University Medical Center Aachen Germany

4. Department of General Pediatrics, Neonatology and Pediatric Cardiology University Children's Hospital, Heinrich Heine University Düsseldorf Germany

5. Laboratory of Genetic Metabolic Diseases, Gastroenterology, Endocrinology & Metabolism Amsterdam University Medical Centers Amsterdam The Netherlands

6. Department of Child Neurology Emma Children's Hospital, and Amsterdam Neuroscience, Cellular & Molecular Mechanisms, Vrije Universiteit Amsterdam The Netherlands

7. Department of Pediatrics, Division of Metabolic Disorders Emma Children's Hospital, Gastroenterology, Endocrinology & Metabolism, Amsterdam University Medical Centers Amsterdam The Netherlands

Abstract

AbstractRiboflavin transporter deficiency (RTD) is a genetic disorder of reduced riboflavin (vitamin B2) uptake that causes progressive, multifocal neurological dysfunction. Most patients present in early childhood; if patients present later in life, symptoms usually develop more gradually. We report three previously healthy young adults, who developed rapidly progressive neurological symptoms after decreasing dietary intake of meat and dairy. After a diagnostic odyssey, the diagnosis of a riboflavin transporter deficiency was made. Treatment with high dose oral riboflavin (20–40 mg/kg/day) partially reversed symptoms. This case series highlights that reduced riboflavin intake as a result of dietary changes can unmask RTD at a later age. We emphasize the importance of early recognition of this progressive and potentially lethal disease and show that timely treatment with high dose riboflavin is highly effective.

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3